A transductionally retargeted adenoviral vector for virotherapy of Her2/neu-expressing prostate cancer.
about
New viruses for cancer therapy: meeting clinical needsDevelopment of a generic adenovirus delivery system based on structure-guided design of bispecific trimeric DARPin adaptersPeptide-based technologies to alter adenoviral vector tropism: ways and means for systemic treatment of cancerHigh scFv-receptor affinity does not enhance the antitumor activity of HER2-retargeted measles virus.Adenovirus serotype 5 vectors with Tat-PTD modified hexon and serotype 35 fiber show greatly enhanced transduction capacity of primary cell cultures.Chapter two--Adenovirus strategies for tissue-specific targeting.A vesicular stomatitis virus glycoprotein epitope-incorporated oncolytic adenovirus overcomes CAR-dependency and shows markedly enhanced cancer cell killing and suppression of tumor growth.Changing faces in virology: the dutch shift from oncogenic to oncolytic viruses.Redirecting adenovirus tropism by genetic, chemical, and mechanical modification of the adenovirus surface for cancer gene therapy.Targeting strategies of adenovirus‑mediated gene therapy and virotherapy for prostate cancer (Review).Development of an adenovirus vector vaccine platform for targeting dendritic cells.Designer Oncolytic Adenovirus: Coming of Age.
P2860
Q24567699-88D236D8-0A80-43FE-A980-8A60C29FAD11Q27676519-2091D6F3-D5E8-4B27-918C-C18F44162EF5Q33584756-C6516D7F-41DF-467A-B45E-C0C110FE3BF1Q33896979-880B15D6-5884-4A0E-ACAE-D42D92E797A5Q34571474-DA1FF2E0-65FF-460C-9FF5-E019EAD660D5Q34643252-F3C24A37-6EC2-4C13-BFC3-1AC1BA36272CQ36544244-DE6C3A01-1F7B-4BF4-8A70-8BFEEB6B838AQ38241666-A65744F8-62C0-449B-B486-CEEECC9BD798Q38769919-29B87076-1198-416F-9FC1-2A3464D7F0DBQ45871873-72393B66-A38C-49FC-AC5D-730C817BBC1BQ47248134-B2EF21C9-C777-4498-BCB4-7D3E37D1480EQ55467684-A1391B43-6032-4D72-A6B0-93204ED0D017
P2860
A transductionally retargeted adenoviral vector for virotherapy of Her2/neu-expressing prostate cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
A transductionally retargeted ...... eu-expressing prostate cancer.
@ast
A transductionally retargeted ...... eu-expressing prostate cancer.
@en
type
label
A transductionally retargeted ...... eu-expressing prostate cancer.
@ast
A transductionally retargeted ...... eu-expressing prostate cancer.
@en
prefLabel
A transductionally retargeted ...... eu-expressing prostate cancer.
@ast
A transductionally retargeted ...... eu-expressing prostate cancer.
@en
P2093
P2860
P356
P1433
P1476
A transductionally retargeted ...... eu-expressing prostate cancer.
@en
P2093
C M A De Ridder
K A J Van Schie
L Lindholm
M K Magnusson
M Van der Kroeg
N J Maitland
R C Hoeben
R M Leadley
W M van Weerden
P2860
P356
10.1089/HUM.2011.016
P577
2011-10-12T00:00:00Z